The novel approach of the medication represents a major breakthrough in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide166227.blogoscience.com/48762027/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment